Frequent and recurrent esophageal dysphagia and food impaction? Gastroesophageal reflux symptoms refractor y to therapy? It could be eosinophilic esophagitis.Read More
Give him 90 seconds, and Dr. Stephen Ellis will explain how iFR has improved the prospects for physiologic assessment over what FFR has offered — and why it matters.
High complication rates with conventional treatments for large symptomatic Zenker diverticulum have led to endoscopic procedures that are safer and have similar (or higher) success rates. Here’s a look at the options.
Elizabeth (Tess) Saarel, MD, discusses what steps pediatricians can take to help identify children with inherited heart disease and congenital heart defects who are at risk for SCD.
The goal of thyroid hormone replacement is to achieve clinical and biochemical euthyroidism. Unless there is pituitary compromise, TSH continues to be the most reliable marker of adequacy of thyroid hormone replacement, says Cleveland Clinic’s Christian Nasr. MD.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Anu Suri, MD, staff in the Respiratory Institute, answers three questions about the moral responsibility of physicians to talk with patients about end-of-life care.
ECNO Kelly Hancock discusses how delegation and empowerment are vital to successful nurse leadership. These skills help leaders enhance efficiency, further develop teams, improve patient outcomes, and more.
Stem cells show potential as disease-modifying and restorative therapy in a range of nervous system disorders, but they’re far from ready for prime time. An expert outlines the reasons why and the road ahead.
The new-generation S1P receptor modulator shows impressive effects on relapse rate and MRI lesion activity with no significant safety concerns. The trial’s lead investigator looks ahead to what’s next.
A Cleveland Clinic interventional cardiologist puts the SURTAVI trial in context and speaks to what’s needed to help intermediate-risk patients make the best choice between two good AVR options.